Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect

American Journal of Epidemiology

Volumn 166, Issue 3, 2007, Pages 348-354

  Brookhart, M Alan ^a   Patrick, Amanda R ^a   Dormuth, Colin ^b   Avorn, Jerry ^a   Shrank, William ^a   Cadarette, Suzanne M ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bias (epidemiology); Confounding factors (epidemiology); Epidemiologic methods; Health behavior; Pharmacoepidemiology

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PROSTATE SPECIFIC ANTIGEN;

EPIDEMIOLOGY; HEALTH SERVICES; IMMUNOASSAY; LIFESTYLE; VACCINATION;

ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FOLLOW UP; HAZARD RATIO; HEALTH BEHAVIOR; HUMAN; INFLUENZA VACCINATION; LIFESTYLE; LONG TERM CARE; MAMMOGRAPHY; OBSERVATIONAL STUDY; OCCULT BLOOD; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SELECTION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PREVENTIVE HEALTH SERVICE; SCREENING TEST; STREPTOCOCCUS INFECTION; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; BACTERIAL VACCINES; BIAS (EPIDEMIOLOGY); FEMALE; HEALTH BEHAVIOR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLUENZA VACCINES; LIFE STYLE; MALE; MAMMOGRAPHY; MASS SCREENING; MEDICARE; OCCULT BLOOD; ODDS RATIO; PATIENT COMPLIANCE; PENNSYLVANIA; PREVENTIVE HEALTH SERVICES; PROSTATE-SPECIFIC ANTIGEN; UNITED STATES; VACCINATION;

NORTH AMERICA; PENNSYLVANIA; UNITED STATES;

EID: 34547670103     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm070     Document Type: Article

References (33)

1. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333:15-20.
2. White HD. Adherence and outcomes: it's more than taking the pills. Lancet 2005;366:1989-91.
3. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002;137:273-84.
4. Ray WA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev 2002;8:276-9.
5. Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006;333:999-1003.
6. Haley RW, Dietschy JM. Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease? Arch Neurol 2000;57:1410-12.
7. Glynn RJ, Knight EL, Levin R, et al. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology 2001;12:682-9.
8. Glynn RJ, Schneeweiss S, Wang PS, et al. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol 2006;59:819-28.
9. Chewning B. The healthy adherer and the placebo effect. BMJ 2006;333:18-19.
10. Avorn J. Review: good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortality. ACP J Club 2006;145:80.
11. Petitti DB. Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies? Ann Epidemiol 1994;4:115-18.
12. Rossouw JE. Debate: the potential role of estrogen in the prevention of heart disease in women after menopause. Curr Control Trials Cardiovasc Med 2000;1:135-8.
13. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
14. Garbe E, Suissa S. Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reprod 2004;19:8-13.
15. Redberg RF. Vitamin E and cardiovascular health: does sex matter? JAMA 2005;294:107-9.
16. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35:337-44.
17. Setoguchi S, Glynn RJ, Avorn J, et al. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 2007;115:27-33.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
19. DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993;12:93-102.
20. Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 2000;162:1289-94.
21. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006;35:345-52.
22. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999;10:37-48.
23. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004;15:615-25.
24. Thavendiranathan P, Bagai A, Brookhart MA, et al. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:2307-13.
25. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;81:444-55.
26. Wen SW, Kramer MS. Uses of ecologic studies in the assessment of intended treatment effects. J Clin Epidemiol 1999;52:7-12.
27. Brooks JM, Chrischilles EA, Scott SD, et al. Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa. Health Serv Res 2003;38:1385-402. Erratum in: Health Serv Res 2004;39:693.
28. Johnston SC. Combining ecological and individual variables to reduce confounding by indication: case study - subarachnoid hemorrhage treatment. J Clin Epidemiol 2000;53:1236-41.
29. Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006;17:268-75.
30. Solomon DH, Avorn J, Sturmer T, et al. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 2006;54:1378-89.
31. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
32. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
33. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med 2005;165:2414-19.